| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.489 | 42.940 | 41.241 | 47.030 | 45.254 | 43.614 | 51.142 | 61.152 | 71.371 | 70.247 |
| Total Income - EUR | 43.489 | 42.940 | 41.308 | 47.030 | 45.254 | 47.882 | 51.142 | 61.152 | 71.371 | 70.247 |
| Total Expenses - EUR | 41.347 | 40.667 | 42.381 | 44.633 | 44.848 | 44.938 | 50.986 | 59.726 | 70.130 | 65.420 |
| Gross Profit/Loss - EUR | 2.142 | 2.272 | -1.073 | 2.397 | 406 | 2.944 | 155 | 1.426 | 1.242 | 4.827 |
| Net Profit/Loss - EUR | 837 | 1.843 | -1.486 | 1.927 | 58 | 2.538 | -356 | 845 | 628 | 2.719 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Emedex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.883 | 2.853 | 2.805 | 2.837 | 3.313 | 2.844 | 2.383 | 1.992 | 1.589 | 2.003 |
| Current Assets | 1.612 | 2.449 | 1.918 | 3.625 | 3.269 | 5.905 | 5.800 | 6.944 | 8.269 | 11.375 |
| Inventories | 779 | 1.017 | 688 | 497 | 1.004 | 1.000 | 982 | 1.490 | 638 | 1.195 |
| Receivables | 567 | 561 | 551 | 1.539 | 322 | 0 | 17 | 19 | 613 | 1.711 |
| Cash | 266 | 871 | 679 | 1.589 | 1.943 | 4.905 | 4.801 | 5.436 | 7.017 | 8.469 |
| Shareholders Funds | -739 | 1.112 | -393 | 1.541 | 1.569 | 4.078 | 3.631 | 4.488 | 5.102 | 7.792 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.233 | 4.191 | 5.116 | 4.921 | 5.013 | 4.671 | 4.552 | 4.449 | 4.756 | 5.586 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Emedex Srl